AI assistant
AstraZeneca Pharma India Ltd. — Capital/Financing Update 2019
Apr 30, 2019
60656_rns_2019-04-30_89bd7174-9623-479a-bec1-b0f201872062.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer


April 30, 2019
The manager- Listing BSE Limited Corporate Relationship Dept., 1 51 Floor, New Trading Ring Rotunda Buiding, P J Towers, Dalal Street, Fort, Mumbai 400001
National Stock Exchange of India Ltd. Exchange plaza, 5'11 Floor, Plot No.C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai 400051
Dear Sir,
Sub: SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018- Fund raising by issuance of Debt Securities by Large Entities
We wish to inform you that AstraZeneca Pharma India Limited does not fall under Large Corporate criteria as mentioned in the para 2.2 of the above mentioned SEBI Circular.
This is for your information and record.
Yours faithfully, For AstraZeneca Pharma India Limited
CORPORATE & REGD. OFFICE AstraZeneca Pharma-lndia Ltd. P. B. No. 4525, Block N1, 121h Floor, Manyala Embassy Business Park, Rachenahalli, Ouler Ring Road, Bangalore - 560 045, INDIA
TEL : +91 80 6774 8000 FAX : +91 80 6774 8857 CIN : L24231KA1979PLC003563 WEB : www.astrazeneca.com/indla FACTORY 12th Mile on Bellary Road Venkatala, Kattigenahalli Village Yelahanka Bangalore - 560 063 INDIA
TEL : +91 80 6774 9000
FAX : +91 80 2846 2208 +91 80 6774 9628